Bicycle Therapeutics plc Increase (Decrease) in Prepaid Expense and Other Assets
Bicycle Therapeutics plc (BCYC) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$660.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-07-30
- Bicycle Therapeutics plc increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$469.00K, a 108.37% decline year-over-year.
- Bicycle Therapeutics plc increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$191.00K, a 106.44% decline year-over-year.
- Bicycle Therapeutics plc increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$4.13M.
- Bicycle Therapeutics plc increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $1.38M.
- Bicycle Therapeutics plc increase (decrease) in prepaid expense and other assets for fiscal 2025 was $5.82M, a 184.54% increase from fiscal 2024.
- Bicycle Therapeutics plc increase (decrease) in prepaid expense and other assets for fiscal 2024 was $2.04M, a 1.35% decline from fiscal 2023.
- Bicycle Therapeutics plc increase (decrease) in prepaid expense and other assets for fiscal 2023 was $2.07M, a 2.57% increase from fiscal 2022.
- Bicycle Therapeutics plc increase (decrease) in prepaid expense and other assets for fiscal 2022 was $2.02M, a 32.08% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$469.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$660.00K 10-Q · filed 2026-07-30 | -$4.79M derived: sum of 3 quarters · filed 2026-07-30 | -$3.42M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | -$191.00K 10-Q · filed 2026-04-30 | -$4.32M derived: sum of 2 quarters · filed 2026-04-30 | -$2.95M derived: sum of 3 quarters · filed 2026-04-30 | $2.66M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | -$4.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$2.75M derived: sum of 2 quarters · filed 2026-03-17 | $2.85M derived: sum of 3 quarters · filed 2026-07-30 | $5.82M 10-K · filed 2026-03-17 | |
| 2025-09-30 | $1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $6.98M derived: sum of 2 quarters · filed 2026-07-30 | $9.95M 10-Q · filed 2025-10-30 | $6.75M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | $5.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $8.57M 10-Q · filed 2026-07-30 | $5.37M derived: sum of 3 quarters · filed 2026-07-30 | $1.83M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | $2.97M 10-Q · filed 2026-04-30 | -$232.00K derived: sum of 2 quarters · filed 2026-04-30 | -$3.77M derived: sum of 3 quarters · filed 2026-04-30 | -$3.38M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2024-12-31 | -$3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$6.74M derived: sum of 2 quarters · filed 2026-03-17 | -$6.35M derived: sum of 3 quarters · filed 2026-03-17 | $2.04M 10-K · filed 2026-03-17 | |
| 2024-09-30 | -$3.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$3.15M derived: sum of 2 quarters · filed 2025-10-30 | $5.24M 10-Q · filed 2025-10-30 | $2.70M derived: sum of 4 quarters · filed 2026-03-17 | |
| 2024-06-30 | $393.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $8.78M 10-Q · filed 2025-08-08 | $6.24M derived: sum of 3 quarters · filed 2026-03-17 | $10.22M derived: sum of 4 quarters · filed 2026-03-17 | |
| 2024-03-31 | $8.39M 10-Q · filed 2025-05-01 | $5.85M derived: sum of 2 quarters · filed 2026-03-17 | $9.82M derived: sum of 3 quarters · filed 2026-03-17 | $8.73M derived: sum of 4 quarters · filed 2026-03-17 | |
| 2023-12-31 | -$2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $1.43M derived: sum of 2 quarters · filed 2026-03-17 | $337.00K derived: sum of 3 quarters · filed 2026-03-17 | $2.07M 10-K · filed 2026-03-17 | |
| 2023-09-30 | $3.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $2.88M derived: sum of 2 quarters · filed 2024-10-31 | $4.62M 10-Q · filed 2024-10-31 | $4.50M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-06-30 | -$1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $638.00K 10-Q · filed 2024-08-06 | $521.00K derived: sum of 3 quarters · filed 2025-02-25 | $240.00K derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-03-31 | $1.74M 10-Q · filed 2024-05-02 | $1.62M derived: sum of 2 quarters · filed 2025-02-25 | $1.34M derived: sum of 3 quarters · filed 2025-02-25 | $2.41M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2022-12-31 | -$117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$398.00K derived: sum of 2 quarters · filed 2025-02-25 | $679.00K derived: sum of 3 quarters · filed 2025-02-25 | $2.02M 10-K · filed 2025-02-25 | |
| 2022-09-30 | -$281.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $796.00K derived: sum of 2 quarters · filed 2023-11-02 | $2.14M 10-Q · filed 2023-11-02 | $4.39M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2022-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $2.42M 10-Q · filed 2023-08-03 | $4.67M derived: sum of 3 quarters · filed 2024-02-20 | $5.67M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2022-03-31 | $1.34M 10-Q · filed 2023-05-04 | $3.60M derived: sum of 2 quarters · filed 2024-02-20 | $4.59M derived: sum of 3 quarters · filed 2024-02-20 | $3.39M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2021-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $3.25M derived: sum of 2 quarters · filed 2024-02-20 | $2.05M derived: sum of 3 quarters · filed 2024-02-20 | $2.97M 10-K · filed 2024-02-20 | $3.02M 10-K · filed 2022-03-01 |
| 2021-09-30 | $997.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$203.00K derived: sum of 2 quarters · filed 2022-11-03 | $719.00K 10-Q · filed 2022-11-03 | -$556.00K derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$278.00K 10-Q · filed 2022-08-04 | -$1.55M derived: sum of 3 quarters · filed 2023-02-28 | -$513.00K derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $922.00K 10-Q · filed 2022-05-05 | -$353.00K derived: sum of 2 quarters · filed 2023-02-28 | $687.00K derived: sum of 3 quarters · filed 2023-02-28 | $767.00K derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$235.00K derived: sum of 2 quarters · filed 2023-02-28 | -$155.00K derived: sum of 3 quarters · filed 2023-02-28 | -$502.00K 10-K · filed 2023-02-28 | $49.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.12M derived: sum of 2 quarters · filed 2021-11-04 | $773.00K 10-Q · filed 2021-11-04 | $1.86M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$267.00K 10-Q · filed 2021-08-05 | $818.00K derived: sum of 3 quarters · filed 2022-03-01 | $2.40M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | -$347.00K 10-Q · filed 2021-05-06 | $738.00K derived: sum of 2 quarters · filed 2022-03-01 | $2.32M derived: sum of 3 quarters · filed 2022-03-01 | $2.16M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.66M derived: sum of 2 quarters · filed 2022-03-01 | $2.51M derived: sum of 3 quarters · filed 2022-03-01 | $2.72M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.42M derived: sum of 2 quarters · filed 2020-11-05 | $1.64M 10-Q · filed 2020-11-05 | $1.06M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2019-06-30 | -$155.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $60.00K 10-Q · filed 2020-08-05 | -$513.00K derived: sum of 3 quarters · filed 2021-03-11 | $927.00K derived: sum of 4 quarters · filed 2021-03-11 | |
| 2019-03-31 | $215.00K 10-Q · filed 2020-05-07 | -$358.00K derived: sum of 2 quarters · filed 2021-03-11 | $1.08M derived: sum of 3 quarters · filed 2021-03-11 | ||
| 2018-12-31 | -$573.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $867.00K derived: sum of 2 quarters · filed 2021-03-11 | $1.33M 10-K · filed 2021-03-11 | ||
| 2018-09-30 | $1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.90M 10-Q · filed 2019-11-07 | |||
| 2018-06-30 | $462.00K 10-Q · filed 2019-08-08 | ||||
| 2017-12-31 | $330.00K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |